Latest Articles

Publication Date
All News Scientific
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - Newswire Canada

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer Newswire …

Published: Feb. 3, 2026, 1 p.m.
Read Full Article
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - Yahoo Finance Singapore

Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer Yahoo …

Published: Feb. 3, 2026, 1 p.m.
Read Full Article
How Patients Define Treatment Options in Endometrial Cancer Trials - Medscape

How Patients Define Treatment Options in Endometrial Cancer Trials Medscape

Published: Feb. 2, 2026, 7:08 p.m.
Read Full Article
Thomas Hofmarcher: Endometrial Cancer Case Study in Taiwan - Oncodaily

Thomas Hofmarcher: Endometrial Cancer Case Study in Taiwan Oncodaily

Published: Feb. 1, 2026, 4:57 a.m.
Read Full Article
Complication Rates and Management in Sentinel Lymph Node Biopsy for Endometrial Cancer: A Retrospective Cohort Study - Frontiers

Complication Rates and Management in Sentinel Lymph Node Biopsy for Endometrial Cancer: A Retrospective Cohort Study Frontiers

Published: Jan. 30, 2026, 6:10 p.m.
Read Full Article
Myriam Saadi: An Inverted PORTEC-3 Protocol for High-Risk Endometrial Cancer in Resource-Limited Settings - Oncodaily

Myriam Saadi: An Inverted PORTEC-3 Protocol for High-Risk Endometrial Cancer in Resource-Limited Settings Oncodaily

Published: Jan. 30, 2026, 5:27 p.m.
Read Full Article
Aprea Therapeutics Reports Early Clinical Activity of APR-1051 in Advanced Endometrial Cancer with Significant Tumor Reduction - Quiver Quantitative

Aprea Therapeutics Reports Early Clinical Activity of APR-1051 in Advanced Endometrial Cancer with Significant Tumor Reduction Quiver Quantitative

Published: Jan. 29, 2026, 1:31 p.m.
Read Full Article
Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment - targetedonc.com

Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment targetedonc.com

Published: Jan. 28, 2026, 10:02 p.m.
Read Full Article
Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment - Targeted Oncology

Evaluating the Molecular Landscape in Endometrial Cancer to Optimize Treatment Targeted Oncology

Published: Jan. 28, 2026, 10:02 p.m.
Read Full Article
How Immunotherapy Helps Women With Advanced Endometrial Cancer - Banner Health

How Immunotherapy Helps Women With Advanced Endometrial Cancer Banner Health

Published: Jan. 28, 2026, 7:05 p.m.
Read Full Article
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!